Published online Aug 15, 2023. doi: 10.4239/wjd.v14.i8.1194
Peer-review started: February 3, 2023
First decision: March 1, 2023
Revised: March 9, 2023
Accepted: June 21, 2023
Article in press: June 21, 2023
Published online: August 15, 2023
Processing time: 188 Days and 19.6 Hours
This review describes the prevalence, incidence, and demographics of children and young people (CYP) with type 1 diabetes in England and Wales using data from the United Kingdom National Paediatric Diabetes Audit (NPDA) and has almost 100% submission from all paediatric diabetes centres annually. It is a powerful benchmarking tool and is an essential part of a long-term quality improvement programme for CYP with diabetes. Clinical characteristics of this population by age, insulin regimen, complication rates, health inequalities, access to diabetes technology, socioeconomic deprivation and glycaemic outcomes over the past decade is described in the review. The NPDA for England and Wales is commissioned by the United Kingdom Healthcare Quality Improvement Partnership as part of the National Clinical Audit for the United Kingdom National Service Framework for Diabetes. The rising incidence of Type 1 diabetes is evidenced in the past decade. Reduction in national median glycated hemoglobin for CYP with diabetes is observed over the last 10 years and the improvement sustained by various initiatives and quality improvement pro-grammes implemented with universal health coverage.
Core Tip: This review describes the prevalence, incidence and demographics of children and young people (CYP) with type 1 diabetes in England and Wales using data from the United Kingdom National Paediatric Diabetes Audit. Reduction in national median glycated hemoglobin for CYP with diabetes is seen over the last 10 years and sustained by various initiatives and quality improvement programmes implemented with universal health coverage.